- Clarivate (CLVT, Financial) launches DRG Commercial Analytics 360 to improve medtech commercial strategies.
- The platform integrates provider data with procedure insights for targeted market engagement.
- DRG Commercial Analytics 360 offers a 360-degree market visibility with expert-led data intelligence.
Clarivate Plc (CLVT), a global leader in transformative intelligence, has officially launched its DRG Commercial Analytics 360 solution, tailored to enhance commercial strategies within the medtech industry. This platform amalgamates Procedure Finder's search capabilities with Clarivate's extensive provider and affiliations network, providing medtech companies a potent tool for optimizing strategic planning and improving patient access.
The DRG Commercial Analytics 360 includes crucial features such as integrated healthcare provider data and analytics, which offer insights into patient treatment patterns and network affiliations. The system also provides accurate market segmentation by eliminating code-level duplications, which is vital for precise procedure volume tracking across the U.S. market.
Furthermore, the platform boasts a comprehensive 360-degree market visibility, achieved through modularized claims and code groupings aligned with defined market parameters. This ensures informed resource allocation and market sizing. Backed by in-house medtech experts, Clarivate uses advanced data intelligence to offer nuanced insights, aiding medtech companies in making data-driven decisions.
Juliane Ray, Vice President of Product Management at Clarivate, emphasizes the platform's ability to translate real-world data into more efficient commercial strategies, enhancing both business goals and patient access. Theo McCormick from Bioventus, Inc., supports this claim, noting the shift from competitor-focused tactics to strategic conversations informed by data insights.
The release of DRG Commercial Analytics 360 represents Clarivate's continued dedication to leveraging healthcare data assets for the benefit of medtech companies, promising enhanced commercial performance and engagement strategies in a complex healthcare ecosystem.
